LSCG yields 2000000.00% · JNJ yields 2.13%● Live data
📍 LSCG pulled ahead of the other in Year 1
Combined, LSCG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LSCG + JNJ for your $10,000?
Lighting Science Group Corporation designs, develops, and markets general illumination products that use light emitting diodes (LEDs) as their light source for retailers and original equipment manufacturers in the United States. It offers a range of LED retrofit lamps to fit into existing light fixtures as replacements for traditional incandescent, compact fluorescent, and halogen lamps; and LED luminaires comprising FreeLED, a street lighting solution that uses solar energy as its power source. The company also provides biological lighting products, which include Good Night and Good Day circadian replacement lamps, VividGro grow light product, MyNature Coastal lamps and outdoor luminaires, and MyNature Grow lighting lamps and high bay luminaires. It serves Residential and office, Retail and hospitality, Government-owned and private infrastructure, and School and university markets through branded and co-branded private label programs, direct sales force, distributors, and independent sales agents. Lighting Science Group Corporation was incorporated in 1988 and is headquartered in West Warwick, Rhode Island.
Full LSCG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.